just a few factsNothing going on? I must correct Finallytherock with a few facts:
- Bioasis doubled the # of employees in the company in the 2nd half of last year. All these positions were in the project management area. You don’t do this if you don’t have internal and partner projects to manage.
- They hired Shadow Lake Group to help them identify opportunities with partners and better negotiate commercial terms with partners. SLG is well respected in the industry with a big rolodex.
- They hired NY-headquartered investment bank Ladenburg Thalmann in December to assist the Board in evaluating strategic alternatives, including potential M&A. LT is a great firm (not the top shelf JP Morgan, Morgan Stanley, Goldman) but has an excellent reputation.
Was Bioasis approached with some type of “opportunity” and they brought in experts to help them navigate and see what other “offers” might be out there?
- Companies like SLG and LT are not engaged with a micro-cap company for their monthly retainer fees. They are motivated based on performance bonuses.
- It was announced at the AGM (Dec/2021) that Mario Saltarelli took the additional role of CMO (Chief Medical Officer) for Bioasis. A person with his credentials and experience probably gets asked three times a week to join a company’s board or other position. For him to want to devote more of his precious time to Bioasis activities is a huge endorsement of the future of the company. He would not have done it otherwise.
Remember also that in Nov/2021 Denali announced first human proof of concept for its delivery technology against a lysosomal storage disorder. Bioasis's delivery technology is quantitatively superior preclinically and should perform equal to or better than Denali's according to Dr. Mario Saltarelli.